一个海斯甲基化-MAPK信号轴驱动在低毒胰腺癌中持久的上皮细胞-介质细胞过渡
Brooke A Brown1, Paul J Myers1, Sara J Adair2
1Department of Chemical Engineering, University of Virginia, Charlottesville, Virginia.
Cancer research
|March 12, 2024
概括
胰腺癌的缺氧驱动长期的细胞变化 (上皮-介质细胞过渡) 通过基因素甲基化-MAPK通路. 这个过程促进了化学抵抗,可以通过组合疗法向治疗.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 胰腺管道腺癌 (PDAC) 的特点是密集的肌层,导致瘤缺氧.
- 瘤微环境因素,如缺氧,显著影响癌症的进展和治疗反应.
研究的目的:
- 调查缺氧驱动PDAC中的上皮层-介质酶过渡 (EMT) 的机制.
- 确定潜在的治疗标,以克服胰腺癌中缺氧诱导的化学抵抗.
主要方法:
- 利用多个模型系统研究PDAC细胞中缺氧诱导的EMT.
- 研究了在缺氧驱动的EMT中,组织蛋白甲基化,MAPK信号传递,KDM2A,PP2酸酶和NSD2的作用.
- 在体内评估MAPK抑制剂对抗低氧驱动EMT的疗效.
主要成果:
- 低氧诱导PDAC细胞的持久性,细胞自主EMT通过一个正反基因组甲基化-MAPK信号轴.
- 缺氧减少KDM2A活动,抑制PP2酸酶,稳定NSD2,导致H3K36me2依赖的EMT.
- 组合MAPK抑制剂在体内有效对抗低氧驱动的EMT.
结论:
- 缺氧通过基因组甲基化-MAPK通路促进PDAC中持续的EMT,有助于化学抵抗.
- 通过组合疗法针对这一轴提供了一个潜在的策略,以改善胰腺癌患者的治疗结果.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K


